We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$133M
AUM Growth
+$8.67M
Cap. Flow
+$4.35M
Cap. Flow %
3.28%
Top 10 Hldgs %
16.47%
Holding
228
New
136
Increased
1
Reduced
30
Closed
9

Top Buys

Rank Stock Value
1
RLJ icon
RLJ Lodging Trust
RLJ
+$2.07M
2
PPLI
People Inc
PPLI
+$1.93M
3
LINE
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
+$1.53M
4
GNTX icon
Gentex
GNTX
+$1.43M
5
STAY
Extended Stay America, Inc. Paired Share Unit
STAY
+$1.41M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.98M
2
ABAX
Abaxis Inc
ABAX
+$1.68M
3
IPAR icon
Interparfums
IPAR
+$1.67M
4
AMBA icon
Ambarella
AMBA
+$1.65M
5
PNNT
Pennant Park Investment Corp
PNNT
+$1.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.69%
2 Technology 16.12%
3 Healthcare 13.88%
4 Financials 11.13%
5 Industrials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRI
101
DELISTED
Albany Molecular Research Inc
AMRI
$184K 0.14%
+9,163
New +$155K
CWEI
102
DELISTED
Clayton Williams Energy, Inc.
CWEI
$184K 0.14%
+1,338
New +$171K
SGNT
103
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$183K 0.14%
+7,062
New +$157K
DYAX
104
DELISTED
DYAX CORPORATION
DYAX
$183K 0.14%
+19,085
New +$145K
JIVE
105
DELISTED
Jive Software, Inc.
JIVE
$182K 0.14%
+21,376
New +$169K
XNCR icon
106
Xencor
XNCR
$1.44B
$180K 0.14%
+15,461
New +$152K
FMI
107
DELISTED
Foundation Medicine, Inc.
FMI
$180K 0.14%
+6,682
New +$169K
SZYM
108
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$180K 0.14%
+15,269
New +$163K
RMTI icon
109
Rockwell Medical
RMTI
$26.2M
$179K 0.13%
+135
New +$162K
FLNA
110
Filana Therapeutics
FLNA
$43M
$179K 0.13%
+4,458
New +$165K
KPTI icon
111
Karyopharm Therapeutics
KPTI
$168M
$178K 0.13%
+255
New +$119K
SMCI icon
112
Super Micro Computer
SMCI
$19.5B
$178K 0.13%
+70,620
New +$146K
KEYW
113
DELISTED
The KEYW Holding Corporation
KEYW
$178K 0.13%
+14,124
New +$176K
TSRO
114
DELISTED
TESARO, Inc.
TSRO
$178K 0.13%
+5,727
New +$153K
KYTH
115
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$176K 0.13%
+4,582
New +$160K
AGIO icon
116
Agios Pharmaceuticals
AGIO
$2.16B
$175K 0.13%
+3,819
New +$156K
VIVS
117
VivoSim Labs
VIVS
$1.46M
$175K 0.13%
+87
New +$146K
MBII
118
DELISTED
Marrone Bio Innovations, Inc.
MBII
$175K 0.13%
+15,079
New +$171K
ELLI
119
DELISTED
Ellie Mae Inc
ELLI
$175K 0.13%
5,615
-38,021
-87% -$1.02M
VMEM
120
DELISTED
VIOLIN MEMORY, INC.
VMEM
$175K 0.13%
+9,854
New +$148K
PDFS icon
121
PDF Solutions
PDFS
$2.13B
$174K 0.13%
+8,208
New +$157K
BNNY
122
DELISTED
ANNIES INC COMMON STOCK (DE)
BNNY
$174K 0.13%
5,154
-21,812
-81% -$733K
MRIN
123
DELISTED
Marin Software
MRIN
$173K 0.13%
+350
New +$149K
MXL icon
124
MaxLinear
MXL
$6.49B
$173K 0.13%
+17,178
New +$158K
HOLI
125
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$173K 0.13%
+7,062
New +$153K
3 4
5
6 7

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
ACA
American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
VWM
Vivid Wealth Management West Des Moines, Iowa $247M AUM 30.07% 1-Year Est. Return
AAG
Avalon Advisory Group Wexford, Pennsylvania $248M AUM 11.89% 1-Year Est. Return

Capital Impact Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Capital Impact Advisors held 228 positions worth $133M, up 7% from $124M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Capital Impact Advisors deployed $4.35M of net new capital in Q2 2014, opening 136 new positions and adding to 1 existing holding. Its largest new stake was RLJ Lodging Trust: 76,084 shares worth $2.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Abaxis Inc, an estimated $1.68M trimmed.

  • Capital Impact Advisors's largest Q2 2014 buy was RLJ Lodging Trust: 76,084 shares worth $2.2M.
  • Capital Impact Advisors added most to IPG Photonics in Q2 2014, an estimated $113K increase.
  • Capital Impact Advisors's biggest Q2 2014 reduction was Abaxis Inc, cutting an estimated $1.68M.
  • Capital Impact Advisors fully exited Jazz Pharmaceuticals in Q2 2014, selling an estimated $1.98M.
  • Capital Impact Advisors's ten largest holdings make up 16% of its $133M portfolio in Q2 2014.
  • Capital Impact Advisors opened 136 new positions and closed 9 in Q2 2014.
  • Capital Impact Advisors's portfolio value rose 7% quarter-over-quarter to $133M.

Based on Capital Impact Advisors's 13F filing for Q2 2014, filed 11 Aug 2014.